Moreover, vimentin silencing in nasopharyngal cancer cells inhibits the expression of pro-angiogenic factors VEGF and CD31 as well as the formation of pulmonary metastasis in nude mice [60]. Here, VIM is linked to nasopharyngeal carcinoma.